Clinical Trials List
Protocol NumberB4Z-JE-LYEH
2008-03-01 - 2009-12-31
Phase III
Terminated1
ICD-10F90.1
Attention-deficit hyperactivity disorder, predominantly hyperactive type
ICD-10F90.2
Attention-deficit hyperactivity disorder, combined type
ICD-10F90.8
Attention-deficit hyperactivity disorder, other type
ICD-10F90.9
Attention-deficit hyperactivity disorder, unspecified type
ICD-9314.01
Attention deficit disorder, with hyperactivity
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
67 participants
